AstraZeneca Pharma India has surged 18% to Rs 871 after reporting net profit of Rs 1.77 crore for the quarter ended June 30, 2013 (Q1) on back of higher revenues.The pharmaceutical company had loss of Rs 8.15 crore in year ago quarter and Rs 18.57 crore in preceding quarter.
Revenues from operations for the quarter grew by 37% at Rs 125 crore against Rs 91 crore in the corresponding quarter of previous year, AstraZeneca Pharma India said in a statement.
The stock opened at Rs 760 and hit a high of Rs 878 on BSE. A combined 296,035 shares changed hands on the counter till 1020 hours against an average sub 100,000 shares that were traded daily in past two weeks.
Revenues from operations for the quarter grew by 37% at Rs 125 crore against Rs 91 crore in the corresponding quarter of previous year, AstraZeneca Pharma India said in a statement.
The stock opened at Rs 760 and hit a high of Rs 878 on BSE. A combined 296,035 shares changed hands on the counter till 1020 hours against an average sub 100,000 shares that were traded daily in past two weeks.